Jade Biosciences, Inc. (JBIO) Financials
JBIO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 319.4 million | 23.0 million |
| Dec. 31, 2025 | 349.8 million | 17.3 million |
| Sept. 30, 2025 | 202.5 million | 23.1 million |
| June 30, 2025 | 224.0 million | 22.4 million |
JBIO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -24.1 million | 7.4 million |
| Dec. 31, 2025 | -33.7 million | 9.4 million |
| Sept. 30, 2025 | -22.2 million | 4.3 million |
| June 30, 2025 | -36.7 million | 3.9 million |
JBIO Net Income
No data available :(
JBIO Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 311.3 million | - | 679000 |
| Dec. 31, 2025 | 336.2 million | - | 724000 |
| Sept. 30, 2025 | 198.9 million | - | 747000 |
| June 30, 2025 | 220.9 million | - | 792000 |
JBIO Shares Outstanding
JBIO Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 36.1 million | 7.4 million | - |
| Dec. 31, 2025 | 3000 | 28.5 million | 6.4 million | - |
| Sept. 30, 2025 | 57000 | 22.0 million | 5.4 million | - |
| June 30, 2025 | 136000 | 22.5 million | 5.2 million | - |
JBIO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 9000 |
| Dec. 31, 2025 | - | 9000 |
| Sept. 30, 2025 | - | 12000 |
| June 30, 2025 | - | 1000 |
JBIO
Price: $15.99
52 week price:
Dividend Yield: 14.17%
Earnings Per Share: -2.63 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 552.7 million